Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma

Published:2007-01-01 Issue:12 Volume:23 Page:3113-3122
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Brookman Laurence J.¹,Knowles Lisa J.¹,Barbier Michaela²,Elharrar Brigitte³,Fuhr Rainard⁴,Pascoe Steve¹

Affiliation:

1. Novartis Horsham Research Centre, Horsham, UK

2. Novartis Pharma AG, Basel, Switzerland

3. Aster-Cephac, Paris, France

4. Parexel GmbH, Berlin, Germany

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079907X242863

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating β2-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapy;European Journal of Pharmaceutics and Biopharmaceutics;2024-04

2. Development and Validation of Stability Indicating UV Spectrophotometric Method for Simultaneous Estimation of Indacaterol and Momestasone Furoate in Pharmaceutical Dosage Form;International Journal of Advanced Research in Science, Communication and Technology;2023-08-02

3. Ultra-LABAs for the treatment of asthma;Respiratory Medicine;2019-09

4. Current approaches to the discovery of novel inhaled medicines;Drug Discovery Today;2018-10

5. The Early Clinical Development of Indacaterol;Indacaterol;2013-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP